Israel Englander’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.71M Buy
40,100
+100
+0.3% +$4.47K ﹤0.01% 3939
2026
Q1
$1.93M Sell
40,000
-100
-0.2% -$4.66K ﹤0.01% 3906
2025
Q4
$1.94M Sell
40,100
-117,000
-74% -$5.8M ﹤0.01% 3978
2025
Q3
$7.42M Buy
157,100
+7,000
+5% +$338K ﹤0.01% 2706
2025
Q2
$7.25M Sell
150,100
-270,200
-64% -$13.8M ﹤0.01% 2598
2025
Q1
$23.3M Buy
420,300
+376,200
+853% +$20.4M 0.01% 1374
2024
Q4
$2.13M Sell
44,100
-108,700
-71% -$5.53M ﹤0.01% 3598
2024
Q3
$8.81M Sell
152,800
-63,400
-29% -$3.42M ﹤0.01% 2300
2024
Q2
$10.5M Buy
216,200
+188,700
+686% +$9.1M ﹤0.01% 2039
2024
Q1
$1.34M Buy
+27,500
New +$1.34M ﹤0.01% 4056
2023
Q3
Sell
-30,000
Closed -$1.62M 6526
2023
Q2
$1.62M Sell
30,000
-20,000
-40% -$1.08M ﹤0.01% 3663
2023
Q1
$2.72M Buy
+50,000
New +$2.43M ﹤0.01% 3140
2022
Q4
Sell
-25,000
Closed -$951K 7017
2022
Q3
$951K Buy
+25,000
New +$1.11M ﹤0.01% 4383
2022
Q1
Sell
-150,000
Closed -$7.51M 7444
2021
Q4
$7.51M Buy
+150,000
New +$7.42M ﹤0.01% 2466

Other funds holding SNY

Israel Englander's SNY Position: Q2 2026 in Review

Israel Englander increased its Sanofi (SNY) stake by 8.3% in Q2 2026, buying an estimated $12.8M and bringing the position to 3,727,890 shares worth $159M. The position accounts for 0.06% of the portfolio, ranked #314.

Israel Englander first reported a position in SNY in Q1 2014 and has held it in 35 quarters since. The position peaked at $176M in Q4 2022. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Israel Englander held 3,727,890 shares of Sanofi worth $159M as of Q2 2026.
  • Israel Englander bought 287,236 Sanofi shares in Q2 2026, an estimated $12.8M.
  • Sanofi made up 0.06% of Israel Englander's portfolio in Q2 2026, its #314 holding.
  • Israel Englander first reported a position in Sanofi in Q1 2014 and has held it in 35 quarters since.
  • Israel Englander's Sanofi position peaked at $176M in Q4 2022.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.